Scientist 3
MedPharm
Scientist 3
MedPharm
Topical and transdermal drug delivery CDMO
Position Summary
The Scientist III/ Sr. Scientist is responsible for developing and validating analytical methods to support drug formulation development in a GMP-compliant laboratory. This role involves performing validations, stability testing, and forced degradation studies while ensuring data integrity and regulatory compliance. The scientist will independently manage projects, including literature reviews, experimental design, execution, and reporting. Responsibilities also include authoring technical documents such as method validation protocols, development reports, and SOPs, as well as troubleshooting analytical instrumentation like HPLC and GC. Additionally, the role requires mentoring junior scientists, collaborating with cross-functional teams such as Formulation R&D, Quality Control, and Quality Assurance, and maintaining a safe, well-organized laboratory environment.
Essential Functions
Supervisory responsibilities:
Direct Reports: No
Indirect Reports: Yes
Key Relationships (examples: Depts or Individual positions that this position will be working closely with):
Travel requirements: N/A
Education and Experience
Knowledge, Skills, and Abilities
Physical Demands and Work Environment
While performing the duties of this job, there may be certain physical demands required for the position.
Other Duties
You may be asked to take on any other responsibilities or tasks that are within your skills and abilities whenever reasonably asked.
MedPharm is a contract development and manufacturing organization focused on topical, transdermal, and mucosal drug delivery. It provides end-to-end services from formulation development through clinical and commercial manufacturing, including analytical testing and regulatory support, and operates proprietary delivery platforms such as MedSpray, MedTherm, and AquaRMed to enable multiple administration routes. The company combines contract research with a patent portfolio and offers lifecycle support across development and manufacturing, differentiating itself from competitors. A July 2024 merger with Tergus Pharma expanded capabilities to include hormone-based and highly potent drugs, enhancing scale and scope with the aim of helping pharma and biotech move products from early formulation to scalable manufacturing.
Explore more opportunities at MedPharm